MPM BioImpact’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,000
| Closed | -$4.23M | – | 47 |
|
|
2024
Q4 | $4.23M | Buy |
+50,000
| New | +$4.23M | 0.6% | 39 |
|
|
2024
Q3 | – | Sell |
-132,312
| Closed | -$10.7M | – | 47 |
|
|
2024
Q2 | $10.7M | Buy |
132,312
+18,185
| +16% | +$1.46M | 1.66% | 22 |
|
|
2024
Q1 | $9.11M | Buy |
114,127
+20,740
| +22% | +$1.66M | 1.46% | 25 |
|
|
2023
Q4 | $7.43M | Sell |
93,387
-199
| -0.2% | -$15.8K | 1.74% | 25 |
|
|
2023
Q3 | $6.54M | Hold |
93,586
| – | – | 1.75% | 21 |
|
|
2023
Q2 | $6.73M | Buy |
93,586
+23,184
| +33% | +$1.67M | 1.35% | 23 |
|
|
2023
Q1 | $4.34M | Buy |
70,402
+18,427
| +35% | +$1.14M | 1.13% | 23 |
|
|
2022
Q4 | $4.01M | Buy |
+51,975
| New | +$4.01M | 1.04% | 21 |
|
|
2022
Q2 | – | Sell |
-99,834
| Closed | -$4.13M | – | 39 |
|
|
2022
Q1 | $4.13M | Sell |
99,834
-3,571
| -3% | -$148K | 1.11% | 25 |
|
|
2021
Q4 | $3.91M | Sell |
103,405
-6,750
| -6% | -$255K | 0.71% | 27 |
|
|
2021
Q3 | $3.63M | Buy |
+110,155
| New | +$3.63M | 0.56% | 32 |
|